Opioid Use and Morbidities during Left Ventricular Assist Device Support

Area of Science:

• Cardiology
• Pharmacology
• Medical Devices

Background:

• Opioid use is rising among patients with left ventricular assist devices (LVADs).
• The clinical implications of opioid use in this population are not well understood.

Purpose of the Study:

• To investigate the association between opioid use and morbidities in patients receiving LVAD support.

Main Methods:

• Retrospective review of clinical data from 136 patients who received LVADs between 2014 and 2017.
• Patients were stratified based on opioid use at 3 months post-LVAD implantation.
• Analysis of baseline and 3-month clinical parameters, hemodynamic data, and 1-year morbidities and survival.

Main Results:

• The opioid group (57% of patients) showed lower hemoglobin and albumin, and higher C-reactive protein at baseline and 3 months.
• Opioid users exhibited poorer hemodynamics, including elevated pulmonary capillary wedge pressure and central venous pressure.
• Higher incidences of gastrointestinal bleeding (31% vs. 17%) and sepsis (30% vs. 13%) were observed in the opioid group within 1 year.

Conclusions:

• Opioid use in LVAD patients is associated with adverse hemodynamic profiles and increased morbidity.
• While survival was not significantly impacted, the link between opioids and complications warrants further investigation into causality.